Welcome to the new ebulletin for the Faculty
For information published before 29 April 2014, please see the old ebulletin
New submissions can be sent to ebulletin@monash.edu

Wednesday, 24 September 2014

Funding opportunity through Shionogi & Co Ltd for early project support.

Click here to view Shionogi & Co Ltd Science Program 2014

The Shionogi pharmaceutical company in Japan is very keen to receive expressions of interest from Australian researchers for the ​​Shionogi Science Program 2014 which provides between AUD50,000 to AUD150,000 per year for up to 5 years. 

Applications open: Wednesday 1 October 2014​Submission closing date: Friday 31 October 2014

​Please submit applications through the MRO Research Grants and Contracts Team - adm-researchgrants.contracts@monash.edu

Priority areas:

· Novel target molecules for drug discovery to treat obesity or non-alcoholic steatohepatitis (NASH)

· Novel target molecules for drug discovery to treat serious bacterial-/fungal-infectious diseases or emerging and re-emerging infectious diseases

· Novel target molecules, analytical methods and biomarkers to maximize clinical efficacy of therapeutic cancer peptide vaccines

· Novel target molecules for drug discovery to treat cancer

· Novel target molecule, analytical methods and promising models for drug discovery to treat psoriasis and/or atopic dermatitis (pruritus)

· Ideas for novel technologies and methods for drug discovery to treat central nervous system (CNS) diseases

· Ideas for novel biomarkers and target molecules for chronic pain

· Ideas for practical biomarker detection technologies for patient segmentation

· Ideas for novel next generation therapeutic modalities

· Ideas for novel technology of drug formulation

For more information visit: http://www.shionogi.co.jp/ssp/

No comments:

Post a Comment